TrialJournal of the European Academy of Dermatology and Venereology : JEADV2026

Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study.

Lin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.